Publications by authors named "Sha Fu"

Claim this Profile
A
A Generative Foundation Model for Scalable Cytology Image Synthesis in AI-Powered Diagnostics.
Ke Zheng, Xueyi Zheng, Jue Wang, Xinke Zhang, Shiping Chen, Sha Fu

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between clopidogrel use and improved survival in critically ill patients with acute kidney injury: insights from MIMIC-IV database.
Yuqi Zhu, Jinglin Hai, Chen Wu, Jiaxiao Li, Ting Xue, Sha Fu

BMC Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival with PD-1/PD-L1 inhibitors plus platinum-based chemotherapy versus chemotherapy alone in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma: updated follow-up analysis.
Yanna Tang, Wei Du, Xuanye Zhang, Xuan Yang, Yixin Zhou, Sha Fu

Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results.
Niu Liu, Jiaying Wu, Enze Deng, Jianglong Zhong, Bin Wei, Sha Fu

Nat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenocarcinoma of the rete testis: clinicopathological study of 18 cases with emphasis on MET amplification and a review of the literature.
Ya Chen, Yanjun Chen, Qi Sun, Xinghua Hou, Sha Fu

Histopathology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative immunotherapy plus chemotherapy versus chemotherapy alone for patients with resectable pulmonary lymphoepithelioma-like carcinoma.
Mengjie Lei, Xuanye Zhang, Li-Na Hu, Sha Fu, Meihua Xiao

Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than meets the eye: predicting adrenocortical carcinoma outcomes with pathomics.
Jianqiu Kong, Mingli Luo, Yi Huang, Ying Lin, Kaiwen Tan, Sha Fu

Eur J Endocrinol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-terminal pro-B-type natriuretic peptide, eGFR, and progression of kidney disease in chronic kidney disease patients without heart failure.
Yi Lu, Junzhe Chen, Licong Su, Andrew Fanuel Lukwaro, Shiyu Zhou, Sha Fu

Clin Kidney J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials.
Yixin Zhou, Hui Yu, Chen Chen, Anlin Li, Xuanye Zhang, Sha Fu

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning models for thyroid nodules diagnosis of fine-needle aspiration biopsy: a retrospective, prospective, multicentre study in China.
Jue Wang, Nafen Zheng, Huan Wan, Qinyue Yao, Shijun Jia, Sha Fu

Lancet Digit Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-specific mutations serve as a potential biomarker for homologous recombination deficiency in breast cancer: a clinical next-generation sequencing study.
Yongsheng Huang, Shuwei Ren, Linxiaoxiao Ding, Yuanling Jiang, Jiahuan Luo, Sha Fu

Precis Clin Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Yongsheng Huang, Peiliang Lin, Jianwei Liao, Faya Liang, Ping Han, Sha Fu

BMC Endocr Disord· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer.
Jue Wang, Yunfang Yu, Yujie Tan, Huan Wan, Nafen Zheng, Sha Fu

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis.
Yixin Zhou, Anlin Li, Hui Yu, Yuhong Wang, Xuanye Zhang, Sha Fu

JAMA Netw Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study.
Yongsheng Huang, Yuntan Qiu, Linxiaoxiao Ding, Shuwei Ren, Yuanling Jiang, Sha Fu

J Pathol Clin Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of Peripheral Blood Inflammatory Indicators to Prognosis After Intravenous Thrombolysis in Acute Ischemic Stroke: A Retrospective Study.
Tianrui Zhang, Sha Fu, Xiaofeng Cao, Yangjingyi Xia, Manyan Hu

Int J Gen Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis.
Yuxin Luo, Qirong Song, Jiaxiao Li, Sha Fu, Wenjuan Yu

BMC Nephrol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
Xing He, Yaorong Peng, Gui He, Huilin Ye, Liqiang Liu, Sha Fu

J Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8 T-Cell Dysfunction in NSCLC.
Anlin Li, Yuanyuan Wang, Zhixin Yu, Zihui Tan, Lina He, Sha Fu

J Thorac Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR3 Alterations in Bladder Cancer Stimulate Serine Synthesis to Induce Immune-Inert Macrophages That Suppress T-cell Recruitment and Activation.
Yi Ouyang, Ziwei Ou, Wenlong Zhong, Jin Yang, Sha Fu

Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
Xing He, Yaorong Peng, Gui He, Huilin Ye, Liqiang Liu, Sha Fu

J Transl Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.
Li-Na He, Tao Chen, Sha Fu, Yongluo Jiang, Xuanye Zhang

Ther Adv Med Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering transcriptomic determinants of the divergent link between PD-L1 and immunotherapy efficacy.
Anlin Li, Linfeng Luo, Wei Du, Zhixin Yu, Lina He, Sha Fu

NPJ Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy.
Li-Na He, Haifeng Li, Wei Du, Sha Fu, Linfeng Luo

iScience· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancer.
Yixing Wang, Sha Fu, Xuanye Zhang, Wei Du, Linfeng Luo

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis